431 related articles for article (PubMed ID: 14704791)
1. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
Khanna C; Wan X; Bose S; Cassaday R; Olomu O; Mendoza A; Yeung C; Gorlick R; Hewitt SM; Helman LJ
Nat Med; 2004 Feb; 10(2):182-6. PubMed ID: 14704791
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
Wan X; Mendoza A; Khanna C; Helman LJ
Cancer Res; 2005 Mar; 65(6):2406-11. PubMed ID: 15781656
[TBL] [Abstract][Full Text] [Related]
3. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.
Elliott BE; Meens JA; SenGupta SK; Louvard D; Arpin M
Breast Cancer Res; 2005; 7(3):R365-73. PubMed ID: 15987432
[TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
[TBL] [Abstract][Full Text] [Related]
5. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
6. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
8. High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis.
Ogino W; Takeshima Y; Mori T; Yanai T; Hayakawa A; Akisue T; Kurosaka M; Matsuo M
J Pediatr Hematol Oncol; 2007 Jul; 29(7):435-9. PubMed ID: 17609619
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
10. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
[TBL] [Abstract][Full Text] [Related]
11. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
[TBL] [Abstract][Full Text] [Related]
12. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
[TBL] [Abstract][Full Text] [Related]
13. Ezrin and moesin expression in canine and feline osteosarcoma.
Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
[TBL] [Abstract][Full Text] [Related]
14. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
15. Ras/Raf/MEK/ERK pathway is associated with lung metastasis of osteosarcoma in an orthotopic mouse model.
Yu Y; Luk F; Yang JL; Walsh WR
Anticancer Res; 2011 Apr; 31(4):1147-52. PubMed ID: 21508358
[TBL] [Abstract][Full Text] [Related]
16. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
[TBL] [Abstract][Full Text] [Related]
17. Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment.
Heiska L; Melikova M; Zhao F; Saotome I; McClatchey AI; Carpén O
Oncogene; 2011 Dec; 30(50):4953-62. PubMed ID: 21666723
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
[TBL] [Abstract][Full Text] [Related]
19. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.
Tan M; Li P; Klos KS; Lu J; Lan KH; Nagata Y; Fang D; Jing T; Yu D
Cancer Res; 2005 Mar; 65(5):1858-67. PubMed ID: 15753384
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma.
Ren L; Hong SH; Chen QR; Briggs J; Cassavaugh J; Srinivasan S; Lizardo MM; Mendoza A; Xia AY; Avadhani N; Khan J; Khanna C
Cancer Res; 2012 Feb; 72(4):1001-12. PubMed ID: 22147261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]